Salidroside protects against myocardial infarction via activating MIF-mediated mitochondrial quality control

Salidroside protects against myocardial infarction via activating MIF-mediated mitochondrial quality control

Abstract Background Salidroside is a potential therapeutic agent for myocardial infarction (MI), exerting therapeutic effects on macrophage migration inhibitory factor (MIF)-regulated mitochondrial quality control. Our aim was to explore the mechanism through which the MIF pathway regulates salidros...

Full description

Saved in:

Bibliographic Details
Main Authors:	Baiyang You, Jie Zhang, Chuyan Yang, Yaoshan Dun, Dake Qi, Yuqiong Long, Jing Cheng, Yuan Lin, Nanjiang Zhou, Tanghao Zeng, Jie Dong, Suixin Liu
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	Chinese Medicine
Subjects:	Salidroside Macrophage migration inhibitory factor Myocardial infarction Cardiomyocyte apoptosis Mitochondrial quality control
Online Access:	https://doi.org/10.1186/s13020-025-01076-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of salidroside on the immune function of BCG-infected macrophages
by: NI Shuyi, et al.
Published: (2025-04-01)

Salidroside ameliorates diabetic amyotrophy by targeting Caspase-3 to inhibit apoptosis
by: Hejie Wang, et al.
Published: (2025-07-01)

Assessing the potential impact of salidroside on Chikungunya virus-induced acute interstitial nephritis via network pharmacology, molecular docking and in vitro experiments
by: Sheng Cheng, et al.
Published: (2025-07-01)

15-Lipoxygenase-2 deficiency induces foam cell formation that can be restored by salidroside through the inhibition of arachidonic acid effects
by: Huang Rong, et al.
Published: (2025-04-01)

Salidroside: An Overview of Its Promising Potential and Diverse Applications
by: Keke Liang, et al.
Published: (2024-12-01)

Salidroside alleviates ferroptosis of retinal ganglion cells in db/db mice
by: Wenqiang Liu, et al.
Published: (2025-06-01)

Mitochondrial apoptosis in response to cardiac ischemia-reperfusion injury
by: Kaixin Wang, et al.
Published: (2025-01-01)

Salidroside targeted cytosolic phospholipase A2 and regulated arachidonic acid metabolomics to attenuate atherosclerosis progression
by: Qing Liao, et al.
Published: (2025-12-01)

Salidroside ameliorates abnormalities in electrophysiological indices induced by perfusion of the heart with low-potassium solutions
by: Ruoning Yang, et al.
Published: (2025-08-01)

Salidroside can protect against ferroptosis in cardiomyocytes and may be related to the regulation of GGT1
by: Tianhang Feng, et al.
Published: (2025-05-01)

Prevention of salidroside pre-treatment against ischemia-reperfusion injury in rats after kidney transplantation
by: ZHANG Peng-jie, et al.
Published: (2019-01-01)

Study of Salidroside on Expression of Synaptophysin and Tau in Rats after Local Cerebral Ischemia-reperfusion Injury
by: Yanqing SU, et al.
Published: (2017-12-01)

Salidroside enhances 5-fluorouracil sensitivity against hepatocellular carcinoma via YIPF5-induced mitophagy
by: Sumin Sun, et al.
Published: (2025-01-01)

Salidroside impedes Ang II-infused myocardial fibrosis by activating the SIRT1-Nrf2 pathway
by: Xi Zhu, et al.
Published: (2025-06-01)

Mechanism of salidroside promoting testosterone secretion induced by H2O2 in TM3 Leydig cells based on metabolomics and network pharmacology
by: Zixu Wang, et al.
Published: (2025-02-01)

MIF as an oncogenic driver of low‐heterogeneity melanomas
by: Thuy T. Tran, et al.
Published: (2025-05-01)

Salidroside promotes pro-angiogenesis and repair of blood brain barrier via Notch/ITGB1 signal path in CSVD Model
by: Tu Zhilan, et al.
Published: (2025-02-01)

Kaempferol protects against doxorubicin-induced myocardial damage by inhibiting mitochondrial ROS-dependent ferroptosis
by: Lin Zhang, et al.
Published: (2025-12-01)

Salidroside and exercise performance in healthy active young adults – an exploratory, randomized, double-blind, placebo-controlled study
by: Neil A. Schwarz, et al.
Published: (2024-12-01)

Integrating single-cell RNA-seq, bulk RNA-seq and network pharmacology reveals protective effect of salidroside in peritoneal dialysis-associated peritoneal fibrosis
by: Shuting Li, et al.
Published: (2025-06-01)

BDH2 inhibits MIF and affects the recruitment of macrophages by nasopharyngeal carcinoma
by: SU Jiaming, et al.
Published: (2024-09-01)

Mechanisms underlying targeted mitochondrial therapy for programmed cardiac cell death
by: Fengting Jing, et al.
Published: (2025-04-01)

Salidroside inhibits melanin synthesis and melanoma growth via mTOR and PI3K/Akt pathways
by: Qi Ouyang, et al.
Published: (2025-07-01)

Cardiomyocyte specific CD38 deletion protects heart from acute myocardial infarction by activating Sirt3 signaling pathway
by: Ke Wen, et al.
Published: (2025-05-01)

Metabolic reprogramming via mitochondrial delivery for enhanced maturation of chemically induced cardiomyocyte‐like cells
by: Yena Nam, et al.
Published: (2024-12-01)

Elevated levels of Letm1 drives mitochondrial dysfunction and cardiomyocyte stress-mediated apoptosis in cultured cardiomyocytes
by: Anushka Deshpande, et al.
Published: (2025-08-01)

Salidroside mitigates hydrogen peroxide-induced injury by enhancement of microRNA-27a in human trabecular meshwork cells
by: Jun Zhao, et al.
Published: (2019-12-01)

Salidroside inhibited the proliferation of gastric cancer cells through up-regulating tumor suppressor miR-1343-3p and down-regulating MAP3K6/MMP24 signal molecules
by: Xiaoping Wang, et al.
Published: (2024-12-01)

Macrophage migration inhibitory factor (MIF) in CNS diseases: Functional regulation and potential therapeutic indication
by: Yu Zhang, et al.
Published: (2024-11-01)

Cardiomyocyte proliferation: Advances and insights in macrophage-targeted therapy for myocardial injury
by: Tao Wang, et al.
Published: (2025-05-01)

Exercise enhances cardiomyocyte mitochondrial homeostasis to alleviate left ventricular dysfunction in pressure overload induced remodelling
by: Zhichao Ma, et al.
Published: (2025-04-01)

Salidroside alleviates Aβ1–42-induced ferroptosis in human neuroblastoma cells by AKT/GSK-3β activation via inhibiting VDAC1
by: Bensi Zhang, et al.
Published: (2025-08-01)

Corrigendum: Mitochondrial-derived vesicles protect cardiomyocytes against hypoxic damage
by: Binghu Li, et al.
Published: (2025-04-01)

Migration inhibitory factor and cluster of differentiation 74‐mediated dendritic cell apoptosis exacerbates acute acetaminophen‐induced liver injury
by: Zezhou Wu, et al.
Published: (2023-04-01)

Mesenchymal stem cells enchanced by salidroside to inhibit ferroptosis and improve premature ovarian insufficiency via Keap1/Nrf2/GPX4 signaling
by: Lixuan Chen, et al.
Published: (2025-12-01)

EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
by: A. T. Teplyakov, et al.
Published: (2016-03-01)

Estrogen via GPER downregulated HIF-1a and MIF expression, attenuated cardiac arrhythmias, and myocardial inflammation during hypobaric hypoxia
by: Prosperl Ivette Wowui, et al.
Published: (2025-03-01)

Cell division cycle protein 42-driven activation of the MKK3/6-p38 signaling pathway participates in cardiac remodeling in mice
by: Ke Wen, et al.
Published: (2025-07-01)

Macrophage bibliometric study and visualization in myocardial ischemia–reperfusion
by: Zhenhao Li, et al.
Published: (2025-08-01)

Synergistic combinations of Angelica sinensis for myocardial infarction treatment: network pharmacology and quadratic optimization approach
by: Wen-Di Wang, et al.
Published: (2024-12-01)